Mill Capital Management LLC acquired a new position in CME Group Inc. (NASDAQ:CME – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,500 shares of the financial services provider’s stock, valued at approximately $994,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Lederer & Associates Investment Counsel CA raised its position in CME Group by 13.1% during the second quarter. Lederer & Associates Investment Counsel CA now owns 5,424 shares of the financial services provider’s stock valued at $1,198,000 after acquiring an additional 627 shares in the last quarter. Handelsbanken Fonder AB grew its position in CME Group by 0.7% in the second quarter. Handelsbanken Fonder AB now owns 129,709 shares of the financial services provider’s stock worth $28,644,000 after acquiring an additional 915 shares in the last quarter. Perkins Coie Trust Co increased its stake in shares of CME Group by 9.0% during the 2nd quarter. Perkins Coie Trust Co now owns 2,613 shares of the financial services provider’s stock worth $577,000 after purchasing an additional 215 shares during the last quarter. Financial Management Professionals Inc. increased its stake in shares of CME Group by 24.7% during the 2nd quarter. Financial Management Professionals Inc. now owns 2,053 shares of the financial services provider’s stock worth $453,000 after purchasing an additional 406 shares during the last quarter. Finally, Harrell Investment Partners LLC increased its stake in shares of CME Group by 2.5% during the 2nd quarter. Harrell Investment Partners LLC now owns 26,479 shares of the financial services provider’s stock worth $5,847,000 after purchasing an additional 653 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
CME Group Trading Up 1.0%
CME Group stock opened at $269.80 on Friday. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market capitalization of $97.01 billion, a PE ratio of 22.88, a PEG ratio of 3.11 and a beta of 0.23. The business’s 50-day simple moving average is $250.20 and its 200-day simple moving average is $280.22.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s payout ratio is 44.11%.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the stock. The Goldman Sachs Group reduced their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Wall Street Zen downgraded shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. Piper Sandler cut their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Finally, Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Ten investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $291.81.
Check Out Our Latest Stock Report on CME
Insider Buying and Selling
In related news, Director William R. Shepard acquired 325 shares of the stock in a transaction dated Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the purchase, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by insiders.
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
